NS · Healthcare

Samrat Pharmachem Ltd (530125)

Pharmaceuticals & Biotechnology

Samrat Pharmachem Ltd (530125) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $644.00M, P/E ratio is -19.03, net margin is 0.7%, dividend yield is 0.48%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 530125

Market cap

$644.00M

P/E ratio

-19.03

Net margin

0.7%

Dividend yield

0.48%

Samrat Pharmachem Ltd (530125) — FAQ

What is Samrat Pharmachem Ltd's market cap?

Samrat Pharmachem Ltd (530125) has a reported market cap of $644.00M (data as of 2026-07-10).

What is 530125's P/E ratio?

The price-to-earnings (P/E) ratio for Samrat Pharmachem Ltd (530125) is -19.03 (data as of 2026-07-10).

Does Samrat Pharmachem Ltd pay a dividend?

Samrat Pharmachem Ltd (530125) shows a reported dividend yield of 0.48%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Samrat Pharmachem Ltd in?

Samrat Pharmachem Ltd (530125) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 530125 listed on?

530125 is listed on NS.

What is Samrat Pharmachem Ltd's net margin?

Samrat Pharmachem Ltd (530125) reports a net margin of 0.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)